|
| 36799863 | Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer. | Cancer Res | 2023 |
| 37348462 | Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics. | Cell Syst | 2023 |
| 36799863 | Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer. | Cancer Res | 2023 |
| 37356470 | Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. | Cancer Lett | 2023 |
| 37348462 | Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics. | Cell Syst | 2023 |
| 37356470 | Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. | Cancer Lett | 2023 |
| 36012586 | CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner. | Int J Mol Sci | 2022 |
| 36306264 | RAS oncogene signal strength regulates matrisomal gene expression and tumorigenicity of mouse keratinocytes. | Carcinogenesis | 2022 |
| 36012586 | CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner. | Int J Mol Sci | 2022 |
| 35863434 | The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells. | J Biol Chem | 2022 |
| 36306264 | RAS oncogene signal strength regulates matrisomal gene expression and tumorigenicity of mouse keratinocytes. | Carcinogenesis | 2022 |
| 35863434 | The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells. | J Biol Chem | 2022 |
| 32284588 | Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. | Nat Med | 2020 |
| 31949145 | Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis. | Nat Commun | 2020 |
| 32284588 | Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. | Nat Med | 2020 |
| 32747423 | Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis. | Mol Cancer Ther | 2020 |
| 33066043 | A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma. | Cancers (Basel) | 2020 |
| 31949145 | Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis. | Nat Commun | 2020 |
| 33066043 | A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma. | Cancers (Basel) | 2020 |
| 32747423 | Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis. | Mol Cancer Ther | 2020 |
| 31164412 | T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis. | Mol Cancer Res | 2019 |
| 31748226 | Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. | Sci Transl Med | 2019 |
| 31921386 | Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of <i>CLIC4</i>. | Oncotarget | 2019 |
| 31164412 | T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis. | Mol Cancer Res | 2019 |
| 31748226 | Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. | Sci Transl Med | 2019 |
| 31921386 | Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of <i>CLIC4</i>. | Oncotarget | 2019 |
| 30315240 | Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. | Nat Commun | 2018 |
| 30315240 | Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. | Nat Commun | 2018 |
| 25546487 | An in vitro priming step increases the expression of numerous epidermal growth and migration mediators in a tissue-engineering construct. | J Tissue Eng Regen Med | 2017 |
| 28522584 | Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. | Mol Cancer Ther | 2017 |
| 25546487 | An in vitro priming step increases the expression of numerous epidermal growth and migration mediators in a tissue-engineering construct. | J Tissue Eng Regen Med | 2017 |
| 28522584 | Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. | Mol Cancer Ther | 2017 |
| 27330189 | MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. | Sci Signal | 2016 |
| 27330189 | MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. | Sci Signal | 2016 |
| 26462961 | Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. | ACS Chem Biol | 2016 |
| 26462961 | Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. | ACS Chem Biol | 2016 |
| 24429254 | TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms. | Mol Oncol | 2014 |
| 24429254 | TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms. | Mol Oncol | 2014 |
| 24890385 | An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer. | Breast Cancer Res | 2014 |
| 24890385 | An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer. | Breast Cancer Res | 2014 |
| 23146662 | Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. | Biochem Pharmacol | 2013 |
| 23146662 | Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. | Biochem Pharmacol | 2013 |
| 21173787 | Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. | Pharmacogenomics J | 2012 |
| 22616030 | Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis. | J Pathol Inform | 2012 |
| 22812567 | Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. | Breast Cancer Res | 2012 |
| 21173787 | Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. | Pharmacogenomics J | 2012 |
| 21892208 | GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. | Oncogene | 2012 |
| 22812567 | Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. | Breast Cancer Res | 2012 |
| 22616030 | Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis. | J Pathol Inform | 2012 |
| 21892208 | GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. | Oncogene | 2012 |